Saudi Heart Association (SHA) Guidelines for the Management of Heart Failure

Overview

Journal J Saudi Heart Assoc

Specialty Cardiology & Vascular Diseases

Date 2019 Aug 3

PMID 31371908

Citations 11

Authors

Waleed AlHabeeb

Fakhr Al-Ayoubi

Kamal Alghalayini

Fahad Al Ghofaili

Yahya Al Hebaishi

Abdulrazaq Al-Jazairi

Mouaz H Al-Mallah

Ali Almasood

Maryam Al Qaseer

Shukri Al-Saif

Ammar Chaudhary

Abdelfatah Elasfar

Adel Tash

Mohamed Arafa

Walid Hassan

Affiliations

Soon will be listed here.

Abstract

Heart failure (HF) is the leading cause of morbidity and mortality worldwide and negatively impacts quality of life, healthcare costs, and longevity. Although data on HF in the Arab population are scarce, recently developed regional registries are a step forward to evaluating the quality of current patient care and providing an overview of the clinical picture. Despite the burden of HF in Saudi Arabia, there are currently no standardized protocols or guidelines for the management of patients with acute or chronic heart failure. Therefore, the Heart Failure Expert Committee, comprising 13 local specialists representing both public and private sectors, has developed guidelines to address the needs and challenges for the diagnosis and treatment of HF in Saudi Arabia. The ultimate aim of these guidelines is to assist healthcare professionals in delivering optimal care and standardized clinical practice across Saudi Arabia.

Citing Articles

Status of diabetes mellitus in different regions of KSA and update on its management.

Al-Rasheedi M, Alhazmi Y, AlDaiji L, AlDaiji L, Mobarki F, Almuhaysini K Front Clin Diabetes Healthc. 2025; 5:1482090.

PMID: 39759947 PMC: 11695327. DOI: 10.3389/fcdhc.2024.1482090.

Assessment of Medication Compliance and Follow-Up Clinic Attendance Among Patients With Cardiovascular Diseases in the Jazan Region.

Gosadi I, Moafa M, Magfouri M, Kuriri R, Hattan W, Othathi R Cureus. 2024; 16(7):e63928.

PMID: 39105003 PMC: 11298664. DOI: 10.7759/cureus.63928.

Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations.

Mahmood A, Dhall E, Primus C, Gallagher A, Zakeri R, Mohammed S Eur Heart J Qual Care Clin Outcomes. 2024; 10(7):571-589.

PMID: 38918060 PMC: 11537231. DOI: 10.1093/ehjqcco/qcae053.

The Characteristics and Outcomes of Nonhospitalized Patients With Heart Failure in Saudi Arabia: A Contemporary Single-Center Study.

Chaudhary A, Arshad S, Dahdouleh F, Heaphy E, Koulouridis I Cureus. 2024; 16(1):e51756.

PMID: 38192527 PMC: 10773691. DOI: 10.7759/cureus.51756.

Self-care practices among heart failure patients: A cross-sectional study in Saudi population.

Aljohani K Saudi Med J. 2023; 44(3):277-283.

PMID: 36940960 PMC: 10043890. DOI: 10.15537/smj.2023.44.3.20220799.

References

Pitt B, Zannad F, Remme W, Cody R, CASTAIGNE A, Perez A . The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med. 1999; 341(10):709-17. DOI: 10.1056/NEJM199909023411001. View

Gattis W, Hasselblad V, Whellan D, OConnor C . Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med. 1999; 159(16):1939-45. DOI: 10.1001/archinte.159.16.1939. View

. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000; 283(15):1967-75. View

Hofmann R, Wimmer G, Leisch F . Intravenous amiodarone bolus immediately controls heart rate in patients with atrial fibrillation accompanied by severe congestive heart failure. Heart. 2000; 84(6):635. PMC: 1729506. DOI: 10.1136/heart.84.6.635. View

Connolly S, Hallstrom A, Cappato R, Schron E, Kuck K, Zipes D . Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study. Eur Heart J. 2000; 21(24):2071-8. DOI: 10.1053/euhj.2000.2476. View

Suskin N, Sheth T, Negassa A, Yusuf S . Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001; 37(6):1677-82. DOI: 10.1016/s0735-1097(01)01195-0. View

Kasper E, Gerstenblith G, Hefter G, Van Anden E, Brinker J, Thiemann D . A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002; 39(3):471-80. DOI: 10.1016/s0735-1097(01)01761-2. View

Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A . Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol. 2002; 82(2):149-58. DOI: 10.1016/s0167-5273(01)00600-3. View

Moss A, Zareba W, Hall W, Klein H, Wilber D, Cannom D . Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002; 346(12):877-83. DOI: 10.1056/NEJMoa013474. View

10.

Maisel A, Krishnaswamy P, Nowak R, McCord J, Hollander J, Duc P . Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 2002; 347(3):161-7. DOI: 10.1056/NEJMoa020233. View

11.

Nichol K, Nordin J, Mullooly J, Lask R, Fillbrandt K, Iwane M . Influenza vaccination and reduction in hospitalizations for cardiac disease and stroke among the elderly. N Engl J Med. 2003; 348(14):1322-32. DOI: 10.1056/NEJMoa025028. View

12.

Oseroff O, Retyk E, Bochoeyer A . Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH). Curr Opin Cardiol. 2003; 19(1):26-30. DOI: 10.1097/00001573-200401000-00007. View

13.

Martineau P, Frenette M, Blais L, Sauve C . Multidisciplinary outpatient congestive heart failure clinic: impact on hospital admissions and emergency room visits. Can J Cardiol. 2004; 20(12):1205-11. View

14.

Taylor A, Ziesche S, Yancy C, Carson P, DAgostino Jr R, Ferdinand K . Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004; 351(20):2049-57. DOI: 10.1056/NEJMoa042934. View

15.

Park M, Sangean M, Volpe M, Feltrim M, Nozawa E, Leite P . Randomized, prospective trial of oxygen, continuous positive airway pressure, and bilevel positive airway pressure by face mask in acute cardiogenic pulmonary edema. Crit Care Med. 2004; 32(12):2407-15. DOI: 10.1097/01.ccm.0000147770.20400.10. View

16.

Bardy G, Lee K, Mark D, Poole J, Packer D, Boineau R . Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005; 352(3):225-37. DOI: 10.1056/NEJMoa043399. View

17.

Jaarsma T . Inter-professional team approach to patients with heart failure. Heart. 2005; 91(6):832-8. PMC: 1768956. DOI: 10.1136/hrt.2003.025296. View

18.

Ducharme A, Doyon O, White M, Rouleau J, Brophy J . Impact of care at a multidisciplinary congestive heart failure clinic: a randomized trial. CMAJ. 2005; 173(1):40-5. PMC: 1167811. DOI: 10.1503/cmaj.1041137. View

19.

Mahon N, Murphy R, MacRae C, Caforio A, Elliott P, McKenna W . Echocardiographic evaluation in asymptomatic relatives of patients with dilated cardiomyopathy reveals preclinical disease. Ann Intern Med. 2005; 143(2):108-15. DOI: 10.7326/0003-4819-143-2-200507190-00009. View

20.

Mead G, Elder A, Flapan A, Kelman A . Electrical cardioversion for atrial fibrillation and flutter. Cochrane Database Syst Rev. 2005; (3):CD002903. DOI: 10.1002/14651858.CD002903.pub2. View